Prescription Drug Affordability Board Activity, November 2025

Prescription Drug Affordability Board Activity, November 2025 Activities Summary Colorado:  In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on November 17, 2025 where they…

[...]

Intelligence Alert: Unlicensed med spas are selling unregulated diabetes and weight loss injectables that threaten public safety

front page of pdf about unsafe GLPs at medspas

Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.

[...]

FDA Alert: More Counterfeit Ozempic found in U.S. Supply Chain

The FDA and Novo Nordisk are warning the public about counterfeit Ozempic injections circulating in the legitimate U.S. drug supply chain. The FDA announced the seizure of multiple batches of counterfeit Ozempic 1 mg injections, labeled with lot number PAR1229, on December 5, 2025. Their contents and safety are unverified and pose serious health risks.

[...]

Prescription Drug Affordability Board Activity, October 2025

Prescription Drug Affordability Board Activity, October 2025 Activities Summary Colorado:  Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting was rescheduled from November 14, 2025 to January 9, 2026. Maryland: The PDAB will next…

[...]